Search results
BlackRock, BNP See Plenty of AI Fuel Left to Drive Equity Rally
Financial Post· 6 days agoInvestors and market strategists at major firms including BlackRock Inc. and BNP Paribas Asset...
Japan Tax Revenue Sets New Record Amid Weak Yen, Inflation
Financial Post· 5 days agoTax income for the latest fiscal year rose to ¥72.1 trillion ($446 billion) from ¥71.1 trillion in...
CBD of Denver Announces June Revenue and Successful Exhibition at Mary Jane Trade Fair in Berlin
Fairview Post· 7 days agoDenver, Colorado–(Newsfile Corp. – July 1, 2024) – CBD of Denver, Inc. (OTC Pink: CBDD) today announced that revenue for June 2024 is estimated to be approximately $300,000 ...
Gate.io Enlists Elliptic for Comprehensive Crypto Compliance
Fairview Post· 5 days agoPanama City, Panama–(Newsfile Corp. – July 3, 2024) – Gate.io, a top cryptocurrency exchange and Web3 innovator, today announced it has enlisted Elliptic, the leading provider ...
Wawanesa Named Official Insurance Partner for the Corporation of Massey Hall and Roy Thomson Hall
Digital Journal· 4 days agoFOR MORE INFORMATION, CONTACT: Mima Agozzino Communications... 1P5 GlobeNewswire More from GlobeNewswire Diversified Royalty Corp. Announces July 2024 Cash Dividend TWC Enterprises ...
Blackline Safety Announces Interim CFO
Financial Post· 6 days agoVice President Accounting & Finance, Corporate Controller, Elisa Khuong, CPA, CA, named interim CFO as Company continues active search
Enzolytics, Inc. Enters Into Exclusive Worldwide License for Patented Immunotherapy Cancer Treatment
Digital Journal· 7 days agoENZC continues to explore therapeutic applications of the patent, and is preparing to commence Federal Drug Administration ("FDA") in-vitro studies. ENZC has developed a Statement of Work with a major university in Texas to further this effort.